Insights<\/b> into causes, diagnosis and progress in research.<\/p>\n<\/div><\/div><\/div>Questions & Answers<\/span><\/a><\/div><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div>What is <\/span>Parkinson’s disease?<\/span><\/h3><\/div>Parkinson’s disease is the second most common disease of the central nervous system after Alzheimer’s dementia. It is usually diagnosed between the ages of 50 and 80, with increasing frequency in later life. <\/p>\nThe diagnosis is usually made by a neurologist, who takes a detailed medical history and carries out various tests, such as neurological examinations and imaging procedures (CT or MRI).<\/p>\nParkinson’s disease belongs to the group of synucleinopathies, diseases characterized by the abnormal deposition of alpha-synuclein protein in the central and peripheral nervous system. In Parkinson’s disease, alpha-synuclein accumulates predominantly in neurons, leading to the formation of so-called Lewy bodies and Lewy neurites, which can be detected microscopically in neuropathological examinations. <\/p>\n<\/div><\/div><\/div><\/div><\/div>Dopamine deficiency due to deposits of synuclein<\/span><\/span><\/h2><\/div>Certain nerve cells in the midbrain, which are responsible for the production of the neurotransmitter dopamine, show pronounced synuclein deposits in Parkinson’s patients. The death of these nerve cells and the resulting lack of dopamine leads to the typical motor symptoms. <\/p>\n<\/div><\/div><\/div>What is dopamine used for?<\/h4><\/div>Dopamine is very important for controlling our movements. If there is too little of it, typical Parkinson’s symptoms occur: <\/p>\n\nSlowed movements or lack of movement (akinesia)<\/span><\/li>\nStiff muscles (rigor)<\/span><\/li>\nTrembling, especially at rest (resting tremor)<\/span><\/li>\nBalance problems with impaired postural stability and gait stability (postural instability)<\/span><\/li>\n<\/ul>\n<\/div>Other symptoms may include<\/h4><\/div>\nSleep disorders<\/span><\/li>\nOlfactory disorders<\/span><\/li>\nDepression<\/span><\/li>\nConstipation<\/span><\/li>\nCognitive disorders<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>Progression and frequency<\/span><\/strong>of Parkinson’s disease<\/span><\/h3><\/div>Parkinson’s disease usually develops gradually over a period of years – usually with unspecific early symptoms. As the disease progresses, around 40% of those affected develop cognitive disorders and even dementia. <\/span>The average life expectancy after a diagnosis of Parkinson’s disease is around 10 to 20 years. In Germany, around 250,000 to 400,000 people suffer from Parkinson’s disease. Around 12,500 new cases are diagnosed every year. The incidence increases with age: from 1.4% in 65-year-olds to 3.5% in 85-year-olds. Men are affected slightly more often than women. <\/span><\/span><\/p>\nParkinson’s disease is the second most common neurodegenerative disease worldwide.<\/p>\n<\/div><\/div><\/div><\/div><\/div>How is <\/span>Parkinson’s disease treated?<\/span><\/span><\/span><\/h2><\/div>Medication and supportive therapies can alleviate motor symptoms, but there is currently no cure. The treating neurologist can create an individualized treatment plan tailored to the patient’s specific needs. This plan may include various treatment options: <\/p>\nDrug therapy:<\/b>Drugs such as levodopa can help to compensate for the dopamine deficiency and improve movement symptoms.<\/p>\nPhysiotherapy:<\/b>Regular exercises to improve mobility and balance.<\/p>\nOccupational therapy:<\/b><\/span>Provides support in coping with everyday activities and adapting the living environment.<\/p>\nSpeech therapy:<\/b>Helps with speech and swallowing problems.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/i>Our innovative research approaches at the interface of molecular biology and medicine open up new perspectives in the treatment of neurodegenerative diseases. Through the targeted modulation of pathological protein aggregates, we strive to fundamentally change the course of synucleinopathies such as Parkinson’s disease and MSA. Our work is more than research – it is a promise to patients and their families to relentlessly search for solutions that could improve the lives of millions of people.<\/span> <\/p>\n<\/div><\/div><\/div><\/div><\/div>News & interesting facts<\/h2><\/div>You can find many more exciting articles and scientific background information in our MODAG blog.<\/p>\n<\/div><\/div><\/div>\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>New Standard for Parkinson\u2019s Diagnostics \u2013 German Biotech Company MODAG Unveils World\u2019s First CE-Certified Test Kit<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Parkinson’s disease is the second most common disease of the central nervous system after Alzheimer’s dementia. It is usually diagnosed between the ages of 50 and 80, with increasing frequency in later life. <\/p>\n
The diagnosis is usually made by a neurologist, who takes a detailed medical history and carries out various tests, such as neurological examinations and imaging procedures (CT or MRI).<\/p>\n
Parkinson’s disease belongs to the group of synucleinopathies, diseases characterized by the abnormal deposition of alpha-synuclein protein in the central and peripheral nervous system. In Parkinson’s disease, alpha-synuclein accumulates predominantly in neurons, leading to the formation of so-called Lewy bodies and Lewy neurites, which can be detected microscopically in neuropathological examinations. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Certain nerve cells in the midbrain, which are responsible for the production of the neurotransmitter dopamine, show pronounced synuclein deposits in Parkinson’s patients. The death of these nerve cells and the resulting lack of dopamine leads to the typical motor symptoms. <\/p>\n<\/div><\/div><\/div>
Dopamine is very important for controlling our movements. If there is too little of it, typical Parkinson’s symptoms occur: <\/p>\n
Parkinson’s disease usually develops gradually over a period of years – usually with unspecific early symptoms. As the disease progresses, around 40% of those affected develop cognitive disorders and even dementia. <\/span>The average life expectancy after a diagnosis of Parkinson’s disease is around 10 to 20 years. In Germany, around 250,000 to 400,000 people suffer from Parkinson’s disease. Around 12,500 new cases are diagnosed every year. The incidence increases with age: from 1.4% in 65-year-olds to 3.5% in 85-year-olds. Men are affected slightly more often than women. <\/span><\/span><\/p>\nParkinson’s disease is the second most common neurodegenerative disease worldwide.<\/p>\n<\/div><\/div><\/div><\/div><\/div>How is <\/span>Parkinson’s disease treated?<\/span><\/span><\/span><\/h2><\/div>Medication and supportive therapies can alleviate motor symptoms, but there is currently no cure. The treating neurologist can create an individualized treatment plan tailored to the patient’s specific needs. This plan may include various treatment options: <\/p>\nDrug therapy:<\/b>Drugs such as levodopa can help to compensate for the dopamine deficiency and improve movement symptoms.<\/p>\nPhysiotherapy:<\/b>Regular exercises to improve mobility and balance.<\/p>\nOccupational therapy:<\/b><\/span>Provides support in coping with everyday activities and adapting the living environment.<\/p>\nSpeech therapy:<\/b>Helps with speech and swallowing problems.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/i>Our innovative research approaches at the interface of molecular biology and medicine open up new perspectives in the treatment of neurodegenerative diseases. Through the targeted modulation of pathological protein aggregates, we strive to fundamentally change the course of synucleinopathies such as Parkinson’s disease and MSA. Our work is more than research – it is a promise to patients and their families to relentlessly search for solutions that could improve the lives of millions of people.<\/span> <\/p>\n<\/div><\/div><\/div><\/div><\/div>News & interesting facts<\/h2><\/div>You can find many more exciting articles and scientific background information in our MODAG blog.<\/p>\n<\/div><\/div><\/div>\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>New Standard for Parkinson\u2019s Diagnostics \u2013 German Biotech Company MODAG Unveils World\u2019s First CE-Certified Test Kit<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Parkinson’s disease is the second most common neurodegenerative disease worldwide.<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Medication and supportive therapies can alleviate motor symptoms, but there is currently no cure. The treating neurologist can create an individualized treatment plan tailored to the patient’s specific needs. This plan may include various treatment options: <\/p>\n
Drug therapy:<\/b>Drugs such as levodopa can help to compensate for the dopamine deficiency and improve movement symptoms.<\/p>\n
Physiotherapy:<\/b>Regular exercises to improve mobility and balance.<\/p>\n
Occupational therapy:<\/b><\/span>Provides support in coping with everyday activities and adapting the living environment.<\/p>\nSpeech therapy:<\/b>Helps with speech and swallowing problems.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/i>Our innovative research approaches at the interface of molecular biology and medicine open up new perspectives in the treatment of neurodegenerative diseases. Through the targeted modulation of pathological protein aggregates, we strive to fundamentally change the course of synucleinopathies such as Parkinson’s disease and MSA. Our work is more than research – it is a promise to patients and their families to relentlessly search for solutions that could improve the lives of millions of people.<\/span> <\/p>\n<\/div><\/div><\/div><\/div><\/div>News & interesting facts<\/h2><\/div>You can find many more exciting articles and scientific background information in our MODAG blog.<\/p>\n<\/div><\/div><\/div>\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>New Standard for Parkinson\u2019s Diagnostics \u2013 German Biotech Company MODAG Unveils World\u2019s First CE-Certified Test Kit<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Speech therapy:<\/b>Helps with speech and swallowing problems.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/i>Our innovative research approaches at the interface of molecular biology and medicine open up new perspectives in the treatment of neurodegenerative diseases. Through the targeted modulation of pathological protein aggregates, we strive to fundamentally change the course of synucleinopathies such as Parkinson’s disease and MSA. Our work is more than research – it is a promise to patients and their families to relentlessly search for solutions that could improve the lives of millions of people.<\/span> <\/p>\n<\/div><\/div><\/div><\/div><\/div>News & interesting facts<\/h2><\/div>You can find many more exciting articles and scientific background information in our MODAG blog.<\/p>\n<\/div><\/div><\/div>\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>New Standard for Parkinson\u2019s Diagnostics \u2013 German Biotech Company MODAG Unveils World\u2019s First CE-Certified Test Kit<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Our innovative research approaches at the interface of molecular biology and medicine open up new perspectives in the treatment of neurodegenerative diseases. Through the targeted modulation of pathological protein aggregates, we strive to fundamentally change the course of synucleinopathies such as Parkinson’s disease and MSA. Our work is more than research – it is a promise to patients and their families to relentlessly search for solutions that could improve the lives of millions of people.<\/span> <\/p>\n<\/div><\/div><\/div><\/div><\/div>News & interesting facts<\/h2><\/div>You can find many more exciting articles and scientific background information in our MODAG blog.<\/p>\n<\/div><\/div><\/div>\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>New Standard for Parkinson\u2019s Diagnostics \u2013 German Biotech Company MODAG Unveils World\u2019s First CE-Certified Test Kit<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
You can find many more exciting articles and scientific background information in our MODAG blog.<\/p>\n<\/div><\/div><\/div>
Press<\/a><\/p>\n<\/div>New Standard for Parkinson\u2019s Diagnostics \u2013 German Biotech Company MODAG Unveils World\u2019s First CE-Certified Test Kit<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n\n\t\t\n\t<\/div>\n<\/a><\/div>Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Press<\/a><\/p>\n<\/div>Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA<\/a><\/h4><\/div>Artikel lesen<\/span><\/i><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div>Show all articles<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3822,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":26,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":6001,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/6001"}],"up":[{"embeddable":true,"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/pages\/3822"}],"wp:attachment":[{"href":"https:\/\/www.modag.net\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}